Santen Receives UK Approval for Ryjunea® (low-dose atropine 0.1 mg/ml) to Slow Progression of Childhood Myopia
SANTEN PHARM CO UNSP/ADR (SNPHY)
NASDAQ:AMEX Investor Relations:
santen.com/en/ir
Company Research
Source: PR Newswire
First MHRA-approved low-dose atropine eye drop to slow the progression of myopia (short-sightedness) in children aged 3-14 years with a progression rate of 0.5 D or more per year and a severity of -0.5 D to -6.0 DRates of childhood myopia in the UK have more than doubled over the past 50 years, driven by increased screen time and less outdoor activity[1,2]Part of Santen's global effort to address the growing burden of childhood myopia through early, comprehensive careLONDON and OSAKA, Japan, Nov. 5, 2025 /PRNewswire/ -- Santen today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ryjunea® (low-dose atropine 0.1 mg/ml), the first licensed treatment in the UK to slow the progression of myopia in children.[3] The approval follows the European Commission authorisation and the first launch in Germany earlier this year, with additional launches in Europe to follow.[4,5]Short-sightedness is rising fast among children in the UK, where many childre
Show less
Read more
Impact Snapshot
Event Time:
SNPHY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNPHY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNPHY alerts
High impacting SANTEN PHARM CO UNSP/ADR news events
Weekly update
A roundup of the hottest topics